BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,947,600 | +0.6% | 1,970,000 | 0.0% | 0.25% | +7.3% |
Q2 2023 | $13,868,800 | +50.8% | 1,970,000 | +78.6% | 0.23% | +38.5% |
Q1 2023 | $9,198,094 | +8.9% | 1,102,889 | +5.3% | 0.17% | -54.8% |
Q4 2018 | $8,449,000 | +5.8% | 1,047,000 | 0.0% | 0.37% | +27.6% |
Q3 2018 | $7,989,000 | +461.0% | 1,047,000 | +261.0% | 0.29% | +295.9% |
Q4 2017 | $1,424,000 | -6.3% | 290,000 | 0.0% | 0.07% | -14.0% |
Q3 2017 | $1,520,000 | -5.7% | 290,000 | 0.0% | 0.09% | -14.0% |
Q2 2017 | $1,612,000 | – | 290,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |